sur Jaguar Health, Inc. (NASDAQ:JAGX)
Jaguar Health Launches Neonorm Dog for Digestive Support
Jaguar Health, Inc. has initiated the commercial launch of Neonorm Dog, expanding its Neonorm franchise beyond foals and calves to include canines. The plant-based product aims to support normal stool consistency and gastrointestinal fluid balance in dogs, offering a non-prescription option for pet owners.
Ian Wendt, Chief Business Officer at Jaguar, highlighted the company's dedication to providing a science-based solution for common digestive issues. The new product will soon be available on major platforms like Amazon and Chewy, making it easily accessible to consumers.
Neonorm Dog is derived from the Croton lechleri tree and provides a natural alternative to manage digestive episodes in dogs. Jaguar's CEO, Lisa Conte, emphasized the importance of having a reliable product at hand before symptoms arise. This launch is part of Jaguar's strategy to strengthen its presence in the companion animal market.
R. E.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Jaguar Health, Inc.